Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Derek Chalmers Insider Profile
4 Followers
Derek Chalmers, President & CEO, Director at Cara Therapeutics, holds 991.40K shares in Cara Therapeutics (Ticker: CARA). Most recently, Derek Chalmers Sold $20,000 shares of Cara Therapeutics on Sep 09, 2021 for an estimated value of 309.40K.
Derek Chalmers Cara Therapeutics (CARA)President & CEO, Director
Cara Therapeutics (CARA)
President & CEO, Director
Ranked #10,336 out of 98,743 Corporate Insiders
Profitable Transactions
3 out of 3 Profitable Transactions
Average Return
+84.90%
Average return per transaction
Time Frame
Compare to
Insider Roles
President & CEO, Director
Roles that Derek Chalmers holds in companies
Most Profitable Insider Trade
The most profitable trade made by Derek Chalmers
Derek Chalmers's Trading History
List of latest transactions for each holding click on a transaction to see Derek Chalmers's performance on stock
You May Also Like
Derek Chalmers insider profile FAQ
What is the percentage of profitable transactions made by Derek Chalmers?
The percentage of profitable transactions made by Derek Chalmers is 100%.
What is the average return per transaction made by Derek Chalmers?
The average return per transaction made by Derek Chalmers is 84.90%.
What stocks does Derek Chalmers hold?
Derek Chalmers holds: CARA stocks.
What was Derek Chalmers’s latest transaction?
Derek Chalmers latest transaction was an Informative Sell of $309.40K.
What was Derek Chalmers's most profitable transaction?
Derek Chalmers’s most profitable transaction was an Informative Buy of CARA stock on March 17, 2016. The return on the trade was 207.80%.
What is Derek Chalmers's role in Cara Therapeutics?
Derek Chalmers's role in Cara Therapeutics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.